Spinal Fusion News and Research RSS Feed - Spinal Fusion News and Research

Amedica announces release of Valeo II LL interbody fusion device

Amedica announces release of Valeo II LL interbody fusion device

Amedica Corporation, an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, is pleased to announce the release of its silicon nitride lateral lumbar interbody fusion device. [More]
Novel wound closure technique may reduce complication rates for patients with scoliosis

Novel wound closure technique may reduce complication rates for patients with scoliosis

Patients with scoliosis who undergo surgery may be less likely to develop an infection or other complications after the procedure when a novel wound closure technique pioneered at NYU Langone Medical Center is utilized, according to new research. [More]
FDA grants first cervical multilevel indication to Centinel Spine’s STALIF C integrated interbody device

FDA grants first cervical multilevel indication to Centinel Spine’s STALIF C integrated interbody device

Centinel Spine, Inc., the pioneer of Stand-Alone, No-Profile, Integrated Interbody fusion devices was granted the first cervical multilevel indication for a Stand-Alone interbody device by the U.S. Food and Drug Administration (FDA). [More]
Innovative business ideas presented at PolyU Innovation and Entrepreneurship GSC 2015

Innovative business ideas presented at PolyU Innovation and Entrepreneurship GSC 2015

Organized by The Hong Kong Polytechnic University, PolyU Innovation and Entrepreneurship Global Student Challenge (GSC) 2015 has come to a fruitful close. [More]
Centinel Spine obtains FDA clearance for STALIF MIDLINE, MIDLINE II and MIDLINE II-Ti devices

Centinel Spine obtains FDA clearance for STALIF MIDLINE, MIDLINE II and MIDLINE II-Ti devices

Centinel Spine, Inc., the pioneer of Stand-Alone, No-Profile, Integrated Interbody fusion devices receive FDA clearance for its STALIF MIDLINE, MIDLINE II, MIDLINE II-Ti (Ti-ACTIVE) devices for use with allogeneic bone graft in lumbar spinal fusion procedures. [More]
MIS TLIF surgery results in less pain, shorter hospital stay and faster recovery

MIS TLIF surgery results in less pain, shorter hospital stay and faster recovery

A minimally invasive spinal fusion back surgery results in less blood loss, less postoperative pain, smaller incisions, a shorter hospital stay and faster recovery and return to work. [More]
Loyola surgeon describes the immense benefits of minimally invasive spinal fusion surgery

Loyola surgeon describes the immense benefits of minimally invasive spinal fusion surgery

A minimally invasive spinal fusion back surgery results in less blood loss, less postoperative pain, smaller incisions, a shorter hospital stay and faster recovery and return to work. [More]

Amedica Submits 510(k) Application to FDA for Composite Spinal Interbody Spacers with Porous Silicon Nitride Center

Amedica announced today that it has filed a submission for 510(k) clearance of the Valeo C Interbody with CsC Osteo-Conductive Scaffolding (“Valeo CCsC”) with the U.S. Food and Drug Administration (“FDA”) relating to its composite silicon nitride spinal interbody devices. [More]
Exploring better treatment for adolescent idiopathic scoliosis

Exploring better treatment for adolescent idiopathic scoliosis

Adolescent idiopathic scoliosis (AIS) affects 2-3% of children aged between 10 and 16. It is more common in girls than in boys (with a ratio of 10-1). Besides the obvious physical signs derived from the visible spinal deformity, AIS can cause psychological and emotional problems (low self-esteem, poor self-image body, etc.) that significantly reduces patients' quality of life. [More]
St. Mary's wins Distinguished Hospital Award for Clinical Excellence for second consecutive year

St. Mary's wins Distinguished Hospital Award for Clinical Excellence for second consecutive year

Dignity Health St. Mary's Medical Center has received the Distinguished Hospital Award for Clinical Excellence™ from Healthgrades, the leading online resource for comprehensive information about physicians and hospitals. This is the second consecutive year St. Mary's has received this award, which recognizes St. Mary's as among the top five percent of more than 4,500 hospitals nationwide for clinical performance. [More]
Amedica's CASCADE data shows silicon nitride spacers are comparable to hollow-body PEEK spacers

Amedica's CASCADE data shows silicon nitride spacers are comparable to hollow-body PEEK spacers

Amedica Corporation, a biomaterial company that develops and commercializes silicon nitride ceramics, today released the results of its CASCADE study, a blinded, randomized clinical trial that compared outcomes of spinal fusion surgery between its composite silicon nitride spacers manufactured with a central core of cancellous structured ceramic (CsC), to the gold standard, i.e., PEEK (polyether ether ketone plastic) spacers filled with bone autograft. [More]
Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that the company's Luna 360 Interbody Fusion System has received 510(k) clearance from the U.S. Food and Drug Administration for spinal fusion treatment of symptomatic degenerative disc disease (DDD). [More]
University of Vermont Medical Center recognized with 2014 Partnership in Prevention Award

University of Vermont Medical Center recognized with 2014 Partnership in Prevention Award

The U.S. Department of Health and Human Services, the Association for Professionals in Infection Control and Epidemiology, and the Society for Healthcare Epidemiology of America today recognized the University of Vermont Medical Center with the 2014 Partnership in Prevention Award for achieving sustainable improvements toward eliminating healthcare-associated infections (HAIs). [More]
DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health, today announced the introduction of ViviGen Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects. [More]

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health®, today announced the introduction of ViviGen™ Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects. [More]
Amedica, Spinal Kinetics sign multi-year OEM agreement for silicon nitride spinal implants

Amedica, Spinal Kinetics sign multi-year OEM agreement for silicon nitride spinal implants

Amedica Corporation, a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, is pleased to announce that it has entered into a multi-year original equipment manufacturer (OEM) agreement with Spinal Kinetics, a leading innovator of advanced spinal implant technologies. [More]

MEDICREA receives FDA clearance for world’s first patient-specific spinal osteosynthesis rod

The MEDICREA Group, a company that specializes in the development of personalized implants produced for a patient’s specific need in the treatment of spinal pathologies, today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration for UNiD, the world’s first patient-specific spinal osteosynthesis rod. [More]
Amedica, Spinal Kinetics sign strategic agreement for silicon nitride spinal interbody fusion devices

Amedica, Spinal Kinetics sign strategic agreement for silicon nitride spinal interbody fusion devices

Amedica Corporation, a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopaedic implants, is pleased to announce that it has entered into a multi-year private labeling agreement with Spinal Kinetics, a leading innovator of advanced artificial spinal disc technology. [More]
Basic yoga pose reduces idiopathic scoliosis curves for adolescent, adult patients

Basic yoga pose reduces idiopathic scoliosis curves for adolescent, adult patients

A basic yoga pose, done for an average of only 1.5 minutes a day, six days a week for two months, reduced idiopathic scoliosis curves for adolescent and adult patients an average of 32% in the first peer-reviewed published clinical trial studying yoga for the reduction of scoliosis curves. [More]

Amedica releases Valeo II TL silicon nitride interbody fusion devices

Amedica Corporation, a commercial biomaterial company focused on silicon nitride ceramics as a material platform to develop, manufacture and sell novel medical devices, is pleased to announce the release of its second generation silicon nitride transforaminal lumbar (TL) interbody fusion device. [More]
Advertisement
Advertisement